Moore N - Search Results

1

Impact of prescriber nonresponse on patient representativeness.

Fourrier-Réglat A, Droz-Perroteau C, Bénichou J, Depont F, Amouretti M, Bégaud B, Moride Y, Blin P, Moore N; CADEUS Team. Fourrier-Réglat A, et al. Among authors: moore n. Epidemiology. 2008 Mar;19(2):186-90. doi: 10.1097/EDE.0b013e31816326e9. Epidemiology. 2008. PMID: 18300697

2

Is reporting rate a good predictor of risks associated with drugs?

Pierfitte C, Bégaud B, Lagnaoui R, Moore ND. Pierfitte C, et al. Among authors: moore nd. Br J Clin Pharmacol. 1999 Mar;47(3):329-31. doi: 10.1046/j.1365-2125.1999.00881.x. Br J Clin Pharmacol. 1999. PMID: 10215758 Free PMC article.

3

The link between sunshine and phototoxicity of sparfloxacin.

Pierfitte C, Royer RJ, Moore N, Bégaud B. Pierfitte C, et al. Among authors: moore n. Br J Clin Pharmacol. 2000 Jun;49(6):609-12. doi: 10.1046/j.1365-2125.2000.00212.x. Br J Clin Pharmacol. 2000. PMID: 10848726 Free PMC article.

4

Excess costs related to non-steroidal anti-inflammatory drug utilization in general practice.

Moore N, Verschuren X, Montout C, Callens J, Kong SX, Bégaud B. Moore N, et al. Therapie. 2000 Jan-Feb;55(1):133-6. Therapie. 2000. PMID: 10860014

5

Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability.

Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Bégaud B. Lagnaoui R, et al. Among authors: moore n. Eur J Clin Pharmacol. 2000 May;56(2):181-6. doi: 10.1007/s002280050738. Eur J Clin Pharmacol. 2000. PMID: 10877014

6

Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects.

Moore N, Pierfitte C, Pehourcq F, Lagnaoui R, Bégaud B. Moore N, et al. Clin Pharmacol Ther. 2001 Jun;69(6):445-50. doi: 10.1067/mcp.2001.116147. Clin Pharmacol Ther. 2001. PMID: 11406742

7

Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use.

Fourrier A, Letenneur L, Dartigues JF, Moore N, Bégaud B. Fourrier A, et al. Among authors: moore n. Eur J Clin Pharmacol. 2001 Aug;57(5):419-25. doi: 10.1007/s002280100326. Eur J Clin Pharmacol. 2001. PMID: 11599660

8

Benzodiazepine use in patients hospitalized in a department of internal medicine: frequency and clinical correlates.

Lagnaoui R, Moore N, Longy-Boursier M, Baumevieille M, Bégaud B. Lagnaoui R, et al. Among authors: moore n. Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):531-5. doi: 10.1002/pds.621. Pharmacoepidemiol Drug Saf. 2001. PMID: 11828836

9

Benzodiazepine use and risk of dementia: a nested case-control study.

Lagnaoui R, Bégaud B, Moore N, Chaslerie A, Fourrier A, Letenneur L, Dartigues JF, Moride Y. Lagnaoui R, et al. Among authors: moore n. J Clin Epidemiol. 2002 Mar;55(3):314-8. doi: 10.1016/s0895-4356(01)00453-x. J Clin Epidemiol. 2002. PMID: 11864804

10

Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients.

Montout C, Casadebaig F, Lagnaoui R, Verdoux H, Philippe A, Begaud B, Moore N. Montout C, et al. Among authors: moore n. Schizophr Res. 2002 Oct 1;57(2-3):147-56. doi: 10.1016/s0920-9964(01)00325-5. Schizophr Res. 2002. PMID: 12223245

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,594 results

Search Page

Filters